1.

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands

2.

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands

3.

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands

1.

Survey questionnaire.

2.

Survey questionnaire.

3.

Survey questionnaire.

1.

Focus group discussion diagram.

2.

Focus group discussion diagram.

3.

Focus group discussion diagram.

1.

Themes and quotes from two studies.

2.

Themes and quotes from two studies.

3.

Themes and quotes from two studies.

1.

Focus group questionnaire results.

2.

Focus group questionnaire results.

3.

Focus group questionnaire results.

1.

Africa focus group: Session 1.

2.

Africa focus group: Session 1.

3.

Africa focus group: Session 1.

1.

Africa focus group: Session 2.

2.

Africa focus group: Session 2.

3.

Africa focus group: Session 2.

1.

Africa focus group 3.

2.

Africa focus group 3.

3.

Africa focus group 3.

1.

Tabulated results—African focus group data compilation 2018–2019.

2.

Tabulated results—African focus group data compilation 2018–2019.

3.

Tabulated results—African focus group data compilation 2018–2019.

1.

S1 Fig -

2.

S1 Fig -

3.

S1 Fig -